Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Michael J Asbury"'
Autor:
Geoffrey R Venning, Joan M Clarke, JR Shelton, Gordon T McInnes, Ian R Harrison, LE Ramsay, Michael J Asbury
Publikováno v:
Clinical pharmacology and therapeutics. 30(2)
The renal antimineralocorticoid activity of single oral doses of a new aldosterone antagonist OH OPC(ME)-K was compared to that of spironolactone in two studies in healthy men. OH OPC(ME)-K reversed the urinary electrolyte response to fludrocortisone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3fab7a91be62aae5b1417de3d92c09b
https://pubmed.ncbi.nlm.nih.gov/7249505
https://pubmed.ncbi.nlm.nih.gov/7249505
Autor:
JR Shelton, LE Ramsay, GT McInnes, RM Perkins, JM Clarke, IR Harrison, Michael J Asbury, GR Venning
Publikováno v:
British journal of clinical pharmacology. 13(3)
1 The renal antimineralocorticoid potency of single doses of thirteen compounds with properties in animals compatible with competitive aldosterone antagonism was compared to that of spironolactone in healthy men. 2 Twelve compounds showed significant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0672fac91972f8689cc6addf76e2c3fd
https://pubmed.ncbi.nlm.nih.gov/6460516
https://pubmed.ncbi.nlm.nih.gov/6460516
Publikováno v:
Clinical pharmacology and therapeutics. 21(5)
Relative dose ratios of the mineralocorticoid antagonists spironolactone (100 mg and 200 mg daily) and canrenoate-K (200 mg daily) at steady state were defined in six healthy subjects with fludrecortisone as the mineralocorticoid agonist. The urine l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a770bb8e43ccd3487509062a4ac2d63
https://pubmed.ncbi.nlm.nih.gov/858213
https://pubmed.ncbi.nlm.nih.gov/858213
Autor:
Michael J Asbury, LE Ramsay, Ian R Harrison, JR Shelton, Joan M Clarke, Geoffrey R Venning, Gordon T McInnes
Publikováno v:
Clinical pharmacology and therapeutics. 27(3)
The renal antimineralocorticoid activity of single administration of 2 sulfur-containing compounds, which are thought to be intermediate metabolites of spironolactone, was assessed in healthy subjects. They were each active in reversing the urinary e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f6ae69f5c3b3a7960f059fdd614c7d7
https://pubmed.ncbi.nlm.nih.gov/7357793
https://pubmed.ncbi.nlm.nih.gov/7357793
Publikováno v:
British Journal of Clinical Pharmacology. 9:295P-296P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3571b51183b5d97a5cdde31911dc46bb
https://doi.org/10.1111/j.1365-2125.1980.tb04854.x
https://doi.org/10.1111/j.1365-2125.1980.tb04854.x
Publikováno v:
Journal of Steroid Biochemistry. 8:xx
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62bbcf87aea6059a1e492cab839a54d1
https://doi.org/10.1016/0022-4731(77)90178-9
https://doi.org/10.1016/0022-4731(77)90178-9
Autor:
McInnes, Gordon T, Shelton, John R, Asbury, Michael J, Harrison, Ian R, Clarke, Joan M, Ramsay, Lawrence E, Venning, Geoffrey R
Publikováno v:
Clinical Pharmacology & Therapeutics; Aug1981, Vol. 30 Issue 2, p218-225, 8p
Autor:
McInnes, Gordon T, Asbury, Michael J, Shelton, John R, Harrison, Ian R, Ramsay, Lawrence E, Venning, Geoffrey R, Clarke, Joan M
Publikováno v:
Clinical Pharmacology & Therapeutics; Mar1980, Vol. 27 Issue 3, p363-369, 7p
Autor:
McINNES, GORDON T., ASBURY, MICHAEL J., RAMSAY, LAWRENCE E., SHELTON, JOHN R., HARRISON, IAN R.
Publikováno v:
Journal of Clinical Pharmacology; Aug1982, Vol. 22 Issue 8/9, p410-417, 8p